Class A Shares

Class A Shares

Class A Shares

Phantom Class A shares granted under Long-Term Incentive Plan (includes associated dividend equivalent rights payable in cash).

One Class A share is deliverable for each Phantom Class A share that vests.

Upon termination of service as director, other than because of death, disability or retirement.


Directors Deferred Compensation Stock Units

Common Stock

Each Directors  Deferred Compensation Stock Unit consists of one share of Common Stock credited as units under the Company's Deferred Plan for Directors.

Deferred units are payable commencing six months following the reporting person's retirement or separation from the Board.

Unit price consisting of the closing price of one share of Common Stock.

This total includes reinvested dividends that have been paid on the individual's Directors Deferred securities.

/s/ Katherine A. Lane, Attorney-in-fact for Neal J. Keating


Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.

The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 7, 2024.

Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.

/s/ Kelsey A. Baldwin, attorney-in-fact for Mr. Parker


Consists of shares withheld by the issuer to cover tax withholding obligations in connection with the vesting of restricted stock units under the issuer's 2021 Equity Incentive Plan.


Disposition of shares exempt under Rule 16b-3 as payment of tax liability to Company by delivery or withholding securities incident to vesting of restricted stock units.

Thomas C. Indelicarto by Power of Attorney for D. James Bidzos


This transaction was executed in multiple trades at prices ranging from $41.3300 to $41.7500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, full information regarding the number of shares and prices at which the transaction was effected to the SEC staff, the issuer or a security holder of the issuer. The transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on March 14, 2025.

/s/James D. Small III, Attorney-in-Fact, pursuant to power of attorney previously filed


Shares were sold in multiple transactions at prices ranging from $40.86 to $41.30. Upon written request, the reporting person will provide the number of shares purchased at separate prices to CCBG, any CCBG security holder or the staff of the Securities and Exchange Commission.


On August 14, 2025, the reporting person transferred 200,000 shares of common stock to a grantor trust for which his spouse is the trustee. In exchange for the shares, the trust transferred assets to the reporting person with a fair market value equal to the transferred shares. The transfer of shares to the trust resulted in a decrease in the number of shares the reporting person beneficially owns directly and a corresponding increase in the number of shares the reporting person beneficially owns indirectly through the trust.

On August 8, 2025, in accordance with the provisions of a grantor retained annuity trust ("GRAT E"), 180,080 shares of common stock were distributed from GRAT E to the reporting person as an annuity payment in accordance with the terms of GRAT E.

On August 8, 2025, in accordance with the provisions of a grantor retained annuity trust ("GRAT F"), 500,000 shares of common stock were distributed from GRAT F to the reporting person as an annuity payment in accordance with the terms of GRAT F. The amount of shares available for distribution were insufficient to satisfy the full amount of the annuity payment obligation and so GRAT F was terminated, in accordance with the terms of GRAT F, following the completion of the foregoing distribution.


Common Stock

Each Directors Deferred Compensation Stock Unit consists of one share of Common Stock credited as units under the Company's Deferred Plan for Directors.

Deferred units are payable commencing the fifth business day of January following the reporting person's retirement or separation from the Board.

/s/ Katherine A. Lane, Attorney-in-fact for Anthony Guzzi


Transferred to TOD account held jointly with spouse


Common Stock

Common Stock


This Form 4 reports the withholding of shares by the issuer to cover tax withholding obligations in connection with the vesting of restricted stock units under the issuer's 2021 Equity Incentive Plan.


On June 9, 2023, the reporting person established a grantor retained annuity trust with an independent trustee (the "2023 GRAT"). The reported shares represent an annual annuity payment from the 2023 GRAT to the reporting person.

On June 13, 2024, the reporting person established a grantor retained annuity trust with an independent trustee (the "2024 GRAT"). The reported shares represent an annual annuity payment from the 2024 GRAT to the reporting person.

/s/ Jenna Gallagher for William O. Grabe


By Jose N. Reyes, Jr. Trust, dated August 2, 2021

By Donna Jean Reyes Trust dated August 2, 2021

On August 14, 2025, the reporting person transferred 295,809 shares of Class A Common Stock to the Donna Jean Reyes Trust, dated August 2, 2021, for no consideration. The reporting person is trustee of the trust, and the reporting person and members of his immediate family are the sole beneficiaries of the trust. The reporting person remains the beneficial owner of the securities held by the trust.

Patrick C. Cannon, attorney-in-fact for Jose N. Reyes, Jr.


Includes 1,902 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Michael Rouvina, Attorney-in-Fact for Robert Edward Moritz, Jr.


Common Stock

Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units granted to the Reporting Person.

Each restricted stock unit represents a contingent right to receive one share of PayPal's common stock.

The reporting person received a restricted stock unit grant subject to a three-year vesting schedule, vesting 1/3 on the one year anniversary of the grant date of the restricted stock unit award (the 'Grant Date'), and 1/12 on each quarterly anniversary of the Grant Date thereafter until the third anniversary of the Grant Date, on which date the grant shall be fully vested.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Not applicable.


Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz


Vice President of Finance, Treasurer, Principal Accounting Officer

/s/ Martin Wilson, as attorney-in-fact for John Militello


/s/ Patrick D. Walsh, by attorney-in-fact Meredith W. Cook


Common Stock

This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

The option became fully vested and exercisable on December 15, 2017.


Weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.11 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price. These shares were sold in multiple transactions at prices ranging from $19.53 to $19.90 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

The securities are held by a family trust, of which the reporting person's spouse is the trustee.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This option is fully vested.


These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024.

/s/ Kathy Card Beckles, Attorney-in-fact


Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating
to the vesting of RSUs on May 22, 2025 and May 25, 2025, respectively.

All shares sold at an exact price of $8.87.

/s/ Richard S. Lindahl, Attorney-in-fact


Common Stock

Common Stock

Common Stock

/s/ Michael F. Billotti, attorney-in-fact


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

/s/ Aaron Diamond, attorney-in-fact for Mr. Michael Dornemann


The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.

The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.

The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.

/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook


Contributions to non-profit organizations.

/s/ PAUL DAUBER, attorney-in-fact for Jeffrey P. Bezos, Executive Chair


Common Stock

Common Stock


Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $231.3 to $231.34, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

/s/ Aaron Diamond, attorney-in-fact for Mr. Jon J. Moses


The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2025.


Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.88 to $42.52. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.


These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Shavel on November 25, 2024.


The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Trust for the benefit of the respondent's son for which the respondent's spouse is the trustee


The 10b5-1(c) sales plan was adopted on December 9, 2024.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,448.33 - $5,448.48. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,471.81 - $5,472.51. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,474.70 - $5,474.98. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,476.00 - $5,476.77. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,477.22 - $5,478.20. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,479.44 - $5,480.30. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,480.70 - $5,481.50. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,482.00 - $5,482.77. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.

Represents the weighted average sales price. The range of prices received for the reported transactions was $5,483.10 - $5,484.00. Upon request by the Commission staff, Booking Holdings will provide full information regarding the number of shares sold at each separate price.


The reporting person acquired these shares under a dividend reinvestment plan, pursuant to a dividend reinvestment transaction exempt from Section 16 under Rule 16a-11.

/s/ Jason B. Beauvais , Attorney-in-Fact


Shares beneficially owned directly by Braeside Capital, L.P. ("Braeside Capital").   Braeside Investments, LLC ("Braeside Investments") serves as the investment manager of Braeside Capital. As a co-manager of Braeside Investments, Mr. Stein may be deemed to beneficially own the shares beneficially owned directly by Braeside Capital. Mr. Stein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Shares beneficially owned directly by Braeside Capital II, L.P. ("Braeside Capital II").  Braeside Investments serves as the investment manager of Braeside Capital II. As a co-manager of Braeside Investments, Mr. Stein may be deemed to beneficially own the shares beneficially owned directly by Braeside Capital II. Mr. Stein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.


Represents an award of immediately vested shares of common stock granted to the reporting person as a discretionary bonus as compensation for the reporting person's service as Interim Chief Executive Officer.


The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on April 8, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions on August 14, 2025 at prices ranging from $4.14 to $4.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.


American Depositary Shares

Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.

ADSs acquired upon vesting of Restricted Share Units ("RSUs").

Each RSU represents a contingent right to receive one ADS.

These ADSs were sold automatically to cover taxes upon vesting of RSUs.

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.

The RSUs vest in equal annual installments over four years beginning on 08/14/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2024 by the Reporting Person and was effected to satisfy the Reporting Person's tax obligations upon the vesting of previously granted shares of restricted stock.

/s/ Aaron Diamond, attorney-in-fact for Mr. Michael Sheresky


The transaction reported on this form represents a net settlement related to the vesting of a restricted stock unit award and the withholding of shares to satisfy tax withholding obligations in connection with the vesting event. No shares of stock were sold.

/s/ Siraj Husain by power of attorney previously filed


The shares were sold in multiple trades at prices ranging from $86.54 to $88.05. The price reported above reflects the weighted average sales price.

The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.14 to $42.37. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.


Reporting person sold Common Shares at an average price of $39.0171 of which the Common Shares were sold in multiple transactions at prices ranging from $39.00 and $39.145. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold.


The shares were purchased in multiple trades at prices ranging from $6.7699 to $6.82. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Jeffrey J. Plumer, as attorney-in-fact for Brady Stewart


This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role of Chief Financial Officer of the Company, effective August 15, 2025, and therefore is no longer subject to Section 16 reporting.


/s/ Aaron Diamond, attorney-in-fact for Ms. LaVerne E. Srinivasan


/s/ Aaron Diamond, attorney-in-fact for Mr. Roland A. Hernandez


Class A Common Stock

One share of Class A Common Stock was issued upon the vesting of each Restricted Stock Unit ("RSU").

Each RSU represents a contingent right to receive one share of Class A Common Stock, or at the option of the Compensation Committee, cash of equivalent value.

One sixteenth of the RSUs vested on May 15, 2022 and the remainder will vest in equal quarterly installments through February 15, 2026, in each case subject to continued employment with the Issuer through each vesting date.

CHIEF EXECUTIVE OFFICER, PRESIDENT AND CO-FOUNDER


Class A Common Stock

Class A Common Stock

Class A Common Stock

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $10.02 to $10.27 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 25, 2022.

One sixteenth of the RSUs vested on May 15, 2022 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each vesting date.

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 15, 2023.

One sixteenth of the RSUs vested on May 15, 2023 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each vesting date.

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 15, 2024.

One sixteenth of the RSUs vested on May 15, 2024 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each vesting date.


Class A Common Stock

Class A Common Stock

Represents shares withheld automatically by the Issuer to cover required tax withholding obligations due at settlement of RSUs.

Represents shares withheld automatically by the Issuer to cover required tax withholding obligations due at settlement of restricted stock units previously reported in Table I as Class A Common Stock.

Represents grant of RSUs under the Issuer's Omnibus Equity Incentive Plan granted August 15, 2021.

One quarter of the RSUs vested on August 15, 2022 and the remainder will vest quarterly over the following three years, in each case subject to continued employment with the Issuer through each vesting date.

Represents grant of RSUs under the Issuer's Omnibus Equity Incentive Plan granted March 15, 2022.


Class A Common Stock

Consists of RSUs granted to the Reporting Person on December 6, 2021 pursuant to the Issuer's Omnibus Incentive Plan, each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock, or at the option of the Compensation Committee, cash of equivalent value, upon vesting.

One quarter of such RSUs vested on November 15, 2022, and the remainder will vest quarterly through November 15, 2025, in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.


The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $260.02 - $261.76, inclusive.  The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.


Class A Common Stock

One share of Class A Common Stock was issued upon the vesting of each Restricted Stock Unit ("RSU").

Each RSU represents a contingent right to receive one share of Class A Common Stock, or at the option of the Compensation Committee, cash of equivalent value.

One sixteenth of the RSUs vested on May 15, 2022 and the remainder will vest in equal quarterly installments through February 15, 2026, in each case subject to continued employment with the Issuer through each vesting date.


89 shares were withheld @ $48.44 per share to cover tax liability on 250 restricted shares vesting.

2,937 shares are held in an account at Computershare, which have upcoming vesting dates. 109 shares are dividend reinvested shares for a total of 3,046.

1,416 shares consisting of 1,266 sharers held in an account at Shareworks, and 150 shares held in a brokerage account.

James Davies, POA Amanda Roche, Finance Department Supervisor/VP


The transaction reported on this form represents a net settlement related to the vesting of a restricted stock unit award and the withholding of shares to satisfy tax withholding obligations in connection with the vesting event. No shares of stock were sold.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 25, 2022.

One sixteenth of the RSUs vested on May 15, 2022 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each
vesting date.

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 15, 2023.

One sixteenth of the RSUs vested on May 15, 2023 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each
vesting date.

Represents RSUs granted under the Issuer's Omnibus Equity Incentive Plan on March 15, 2024.

One sixteenth of the RSUs vested on May 15, 2024 and the remainder will vest quarterly over the following four years, in each case subject to continued employment with the Issuer through each
vesting date.


Common Stock

Common Stock

The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 254 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 92 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Represents 74 shares of Common Stock held directly by Earnest Institutional LLC, an affiliate of Earnest Partners LLC, of which Mr. Viera is a partner and the Chief Executive Officer (such securities are not held individually by Mr. Viera). Mr. Viera disclaims beneficial ownership of the securities held by Earnest Institutional LLC except to the extent of his pecuniary interest therein.

Represents 75,000 shares of Common Stock held by The PEV Revocable Living Trust (such securities are indirectly held by Mr. Viera).

/s/ Aaron Diamond, attorney-in-fact for Mr. Paul Viera


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 to $30.50, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Includes 328 shares of Koppers Holdings Inc. common stock acquired pursuant to the Koppers Holdings Inc. Employee Stock Purchase Plan on June 30, 2025. These acquisitions were exempt under both Rule 16b-3(c) and Rule 16b-3(d).

/s/Stephanie L. Apostolou, Attorney in Fact


Weighted average price. Actual prices ranged from $51.69 to $51.73. Full information regarding the number of shares purchased at each separate price will be provided upon request to the SEC's staff, Insperity, Inc. or its stockholders.

/s/ Christian P. Callens, by Power of Attorney


Shares withheld to meet tax liabilities associated with vesting of previously granted restricted stock units.

Includes unvested restricted stock units.

Total number of shares of Common Stock held in the name of the Reporting Person under the Sealed Air Corporation 401(k) and Profit-Sharing Plan as of the date of this Form 4.

/s/Kristina Johnson, attorney-in-fact for Mr. Semach


This Form 4 is filed jointly by Olesen Value Fund L.P., Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen, the address of each of which is c/o Olesen Capital Management LLC, 185 Hudson Street, Suite 2539, Jersey City, NJ 07311 (collectively, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the shares of common Stock reported herein except to the extent of its or his pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Value Fund GP LLC, as the general partner of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Capital Management LLC, as the investment manager of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Christian Olesen, as the managing member of Olesen Value Fund GP LLC and Olesen Capital Management LLC, may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.


The reported shares were transferred as a bona fide charitable gift. No shares were sold.

These shares were withheld to satisfy tax withholding obligations in connection with the vesting of previously awarded Restricted Share Units ("RSUs"). No shares were sold.

Includes 382,918 ordinary shares.

Includes 34,510 RSUs which shall vest in equal quarterly installments through 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 124,107 RSUs which shall vest in equal quarterly installments through 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 180,559 RSUs which shall vest in equal quarterly installments through 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 360,676 RSUs which shall vest in equal quarterly installments through 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 254 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 102 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the D&E Living Trust and the EFS 2020 Irrevocable Trust on March 5, 2025.

Shares held directly by the D&E Living Trust. The Reporting Person and David Siminoff serve as co-trustees and retain voting and dispositive power with respect to the shares held by the D&E Living Trust.

Shares held directly by the EFS 2020 Irrevocable Trust. The Reporting Person serves as trustee and holds voting and dispositive power with respect to these shares.

/s/ Aaron Diamond, attorney-in-fact for Ms. Ellen F. Siminoff


Includes 12,767,568 ordinary shares.

Includes 179,656 RSUs which shall vest in equal quarterly installments through 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 575,854 RSUs which shall vest in equal quarterly installments through 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 869,356 RSUs which shall vest in equal quarterly installments through 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 1,683,154 RSUs which shall vest in equal quarterly installments through 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.


Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

/s/ Danika Haueisen, Attorney-In-Fact for Jaime Ardila


Includes 798,862 ordinary shares.

Includes 53,681 RSUs which shall vest in equal quarterly installments through 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 223,392 RSUs which shall vest in equal quarterly installments through 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 401,241 RSUs which shall vest in equal quarterly installments through 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.

Includes 841,578 RSUs which shall vest in equal quarterly installments through 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.


/s/ Danika Haueisen, Attorney-in-Fact for Martin Brudermueller


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 254 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 70 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

/s/ Aaron Diamond, attorney-in-fact for Mr. William B. Gordon


Class A Common Stock

Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's Class A Common Stock, par value $0.001 per share.

The Restricted Stock Units vest as follows: one-fourth vested on January 18, 2023 with the remaining vesting in 1/48 equal monthly installments until vested in full.


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.82 to $9.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Jongmin Char, as attorney-in-fact for Brian Read


/s/ Danika Haueisen, Attorney-in-Fact for Alan C. Jope


Class A Common Stock


/s/ Danika Haueisen, Attorney-In-Fact for Nancy McKinstry


Reflects an award of time-based restricted stock vesting on December 15, 2025.

/s/ Daniel Swayze by Robert Hickey with Power of Attorney


The sale reported on this Form 4 represents shares sold by the Reporting Person.


/s/ Danika Haueisen, Attorney-in-Fact for Jennifer Nason


This transaction was executed in multiple trades at prices ranging from $1.5150 to $1.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


/s/ Danika Haueisen, Attorney-in-Fact for Paula A. Price


This is the weighted average sales price representing 3,554 shares sold at prices ranging from $126.01 to $126.94 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

This is the weighted average sales price representing 5,746 shares sold at prices ranging from $127.08 to $128.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

This is the weighted average sales price representing 700 shares sold at prices ranging from $128.10 to $128.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Exhibit List - Exhibit 24 - Power of Attorney

/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact


This transaction was executed in multiple trades at prices ranging from $46.51 to $47.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was August 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to August 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

/s/ Aaron Diamond, attorney-in-fact for Ms. Susan Tolson


Class A Common Stock

The Restricted Stock Unit will vest as follows: one-fourth will vest on August 15, 2026 with the remaining vesting in 3 equal annual installments until vested in full.


Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

/s/ Danika Haueisen, Attorney-in-Fact for Venkata S. M. Renduchintala


Shares withheld to cover tax liability associated with the vesting of restricted stock units.


/s/ Danika Haueisen, Attorney-In-Fact for Arun Sarin


/s/ Danika Haueisen, Attorney-in-Fact for Tracey Thomas Travis


/s/ Danika Haueisen, Attorney-in-Fact for Masahiko Uotani


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration.

Shares sold to satisfy tax withholding obligation applicable to the vesting of stock-settled RSUs. These shares were not issued to the Reporting Person.

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Represents the settlement of a portion of RSUs granted to the Reporting Person as disclosed on the Reporting Person's Form 3 filed on September 27, 2024.


/s/ Danika Haueisen, Attorney-in-Fact for Atsushi Egawa


/s/ Danika Haueisen, Attorney in- Fact for Angie Y. Park


The reporting person received restricted stock units ("RSUs") on August 15, 2025, having a value equal to approximately $192,500 based on the closing price per share of the Issuer's common stock on August 15, 2025. The RSUs will vest in three equal installments over three years on August 15 of each of 2026, 2027, and 2028, upon which the RSUs will be settled by delivery of shares of common stock.

/s/ Elliot Kahler, as attorney-in-fact for Jason Williams


Common stock includes restricted stock units.

Thomas L. Doerr, Jr. for Peter A. Kidd (Pursuant to Signing Authority on File)


/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma


This transaction is a gift in which the transaction price is not required to be reported.

/s/ Shaun Patsy, as Attorney-in-Fact for Timothy N. Spence


Represents shares acquired through Equity Residential's Employee Share Purchase Plan.

Direct total includes restricted shares of Equity Residential scheduled to vest in the future.

Represents shares owned by Principal Trust Company, as Trustee of the Equity Residential Supplemental Executive Retirement Plan (the "SERP"), for the benefit of the reporting person.


Common Stock

Common Stock

The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

/s/ Kimberly Cornwell as attorney-in-fact for David Tyronne Howton


/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet


Common Stock

Common Stock

/s/ Kimberly Cornwell as attorney-in-fact for Kevin Tan


Represents shares withheld to satisfy tax withholding obligations upon the vesting and settlement of restricted stock units.

Includes 19,295 restricted stock units.

/s/ Elliot Kahler, as attorney-in-fact for David Vanevenhoven


Common Stock

Common Stock

/s/ Kimberly Cornwell as attorney-in-fact for Paul Herzich


/s/ Danika Haueisen, Attorney-in-Fact for John F. Walsh


The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $42.460 to $42.920, inclusive.  The reporting person undertakes to provide to Fifth Third Bancorp, any security holder of Fifth Third Bancorp, or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

/s/ Stephanie Meade, as Attorney-in-Fact for Kevin J. Khanna


This is the weighted average price.  Shares were sold in multiple transactions at prices ranging from $6.50 to $6.74.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.  The amount reflected has been rounded to four decimal points.


/s/ Scott M. Wilson as Attorney-in-Fact for Mauro Gregorio


Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

/s/ Danika Haueisen, Attorney-in-Fact for Joel Unruch


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares of common stock of the Issuer received on December 21, 2023, as consideration pursuant to that certain Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be further amended and/or restated from time to time, the "Merger Agreement"), by and among Airship AI Holdings, Inc., a Delaware corporation (the "Issuer") (formerly known as BYTE Acquisition Corp., a Cayman Island exempted company limited by shares, prior to its domestication as a Delaware corporation), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of the Issuer, and Airship AI, Inc., a Washington company (formerly known as Airship AI Holdings, Inc., "Airship AI"). The Reporting Person received the reported shares in exchange for shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Airship Kirkland Family Limited Partnership is the record holder of the securities reported herein. Victor Huang is the managing partner of Airship Kirkland Family Limited Partnership and as such has voting and dispositive power over these securities. Mr. Huang disclaims beneficial ownership of the securities held by Airship Kirkland Family Limited Partnership, except to the extent of his pecuniary interest therein.

Represents options to purchase shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of options to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents stock appreciation rights denominated in shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of stock appreciation rights denominated in shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents warrants to purchase shares of common stock of the Issuer received by the Reporting Person on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of warrants to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Pursuant to earnout provisions in the Merger Agreement, the holder of such Earnout Rights is entitled to receive shares of common stock of the Issuer upon the occurrence of certain operating performance and share price performance milestones during the applicable earnout periods set forth in the Merger Agreement.

Options vest quarterly over 4 years.

Public Warrant (AISPW shares) Exercise Price subject to adjustment and expire five years after the closing of the merger on December 21, 2023, or earlier upon redemption or liquidation.


Includes 51,564 restricted stock units.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.74 to $47.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.49 to $48.06 inclusive.

The option vests in three equal annual installments commencing on March 17, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.


/s/ Danika Haueisen, Attorney-in-Fact for Melissa A. Burgum


Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on August 14, 2027, with the remaining 50% vesting on August 14, 2028, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.


/s/ Danika Haueisen, Attorney-in-Fact for Angela Beatty


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration.

Shares sold to satisfy tax withholding obligation applicable to the vesting of stock-settled RSUs. These shares were not issued to the Reporting Person.

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Represents the settlement of a portion of the RSUs granted to the Reporting Person as disclosed on the Reporting Person's Form 4 filed on March 13, 2024.


Common Stock

Common Stock

The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

/s/ Kimberly Cornwell as attorney-in-fact for Gabriel Brooks


Jane R. Grimm, Attorney-in-fact, for Kristin B. McCoy, Executive Vice President, Global Tax


Common Stock

Common Stock

/s/ Kimberly Cornwell as attorney-in-fact for Jessie Hanrahan


W. Nicholas Howley Family Trust u/a/d 4/23/99

Common Stock

The exercise price has been adjusted for dividends declared since August 1, 2022.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,392.9000 - $1,393.0500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,393.9600 - $1,394.6100. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,395.1200 - $1,395.8000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,398.0000 - $1,398.8100. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,399.6500 - $1,400.2500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,402.3100 - $1,402.8475. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,403.4500 - $1,403.6900. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,404.6900 - $1,405.0000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,406.1800 - $1,406.9100. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.


Represents shares acquired through Equity Residential's Employee Share Purchase Plan.

Direct total includes restricted shares of Equity Residential scheduled to vest in the future.

Represents shares acquired through profit sharing contributions and dividend reinvestment activity in the reporting person's account with the Equity Residential Advantage 401(k) Retirement Savings Plan, a plan qualified under Section 401(k) of the Internal Revenue Code of 1986, as amended.  Such shares represent acquisitions through July 16, 2025.


Class A Common Stock

Class A Common Stock

These stock appreciation rights became exercisable in four equal annual installments beginning on May 2, 2020.

These stock appreciation rights became exercisable in four equal annual installments beginning on April 30, 2021.


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of RSUs previously granted to the reporting person. This is not an open market sale of securities.

On August 17, 2020, the reporting person was granted 30,555 RSUs pursuant to the Issuer's Amended and Restated 2019 Omnibus Incentive Compensation Plan, vesting in substantially equal installments on each of the first five anniversaries of the grant date, generally subject to continued service as an officer through each applicable vesting date.

/s/ Sofia Chernylo, by power of attorney


The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.


Common Stock

The option, originally an option for a total of 1,615 shares, vested in four equal annual installments beginning on March 6, 2020, which was the first anniversary of the date of grant.

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.


Common Stock

Common Stock

The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

/s/ Kimberly Cornwell as attorney-in-fact for Alexander Cumbo


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.68, inclusive. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.

Includes (a) 20,000 RSUs that are scheduled to fully vest on August 13, 2026 and (b) 31,585 shares of common stock beneficially owned by the Reporting Person.

The reported securities include (a) 15,000 deferred stock units ("DSUs") granted under the Issuer's 2012 Incentive Compensation Plan and (b) 6,629 DSUs granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.

/s/ Brett W. Johnston, as Attorney-in-Fact


Common Stock

The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.

Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.

Not Applicable


Motorola Solutions, Inc. - Common Stock

Includes shares acquired under the Motorola Solutions Employee Stock Purchase Plan and through the reinvestment of dividends.

$467.4163 is the weighted average sales price. Prices for this transaction ranged from $467.00 to $467.865. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$466.4302 is the weighted average sales price. Prices for this transaction ranged from $465.92 to $466.87. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$465.1894 is the weighted average sales price. Prices for this transaction ranged from $464.92 to $465.81. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$464.4132 is the weighted average sales price. Prices for this transaction ranged from $464.015 to $464.915. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$463.6325 is the weighted average sales price. Prices for this transaction ranged from $463.14 to $464.01. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$462.3512 is the weighted average sales price. Prices for this transaction ranged from $462.175 to $462.975. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$461.8004 is the weighted average sales price. Prices for this transaction ranged from $461.40 to $462.17. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$461.3063 is the weighted average sales price. Prices for this transaction ranged from $461.14 to $461.395. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$461.2575 is the weighted average sales price. Prices for this transaction ranged from $460.925 to $461.825. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

These shares are held in a non-exempt gift trust for the benefit of the reporting person's child.  The reporting person's wife is trustee of this trust.

$460.3827 is the weighted average sales price. Prices for this transaction ranged from $460.01 to $460.855. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$459.5938 is the weighted average sales price. Prices for this transaction ranged from $459.09 to $459.99. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$458.6945 is the weighted average sales price. Prices for this transaction ranged from $458.185 to $459.075. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$457.7629 is the weighted average sales price. Prices for this transaction ranged from $457.49 to $458.03. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$461.4384 is the weighted average sales price. Prices for this transaction ranged from $461.025 to $461.925. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$460.4406 is the weighted average sales price. Prices for this transaction ranged from $460.11 to $461.01. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$459.6868 is the weighted average sales price. Prices for this transaction ranged from $459.21 to $460.105. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$458.7819 is the weighted average sales price. Prices for this transaction ranged from $458.29 to $459.195. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$457.9473 is the weighted average sales price. Prices for this transaction ranged from $457.48 to $458.245. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

These shares are held in an irrevocable trust for the benefit of the reporting person's wife and children. The reporting person's wife is trustee of this trust.

These shares are held in a family trust for the benefit of the reporting person's children. The reporting person's child is trustee of this trust.

These performance based stock options vested on March 10, 2019, upon the attainment of the satisfaction of certain financial performance objectives.

Kristin L. Kruska, on behalf of Gregory Q. Brown, Chairman and Chief Executive Officer (Power of Attorney on File)


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.81 through $67.2486 per share, inclusive. The Filer undertakes to provide Independent Bank Corp., any security holder of Independent Bank Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

/s/ Maureen Gaffney, Power of Attorney for Daniel F. O'Brien


Common Stock

Common Stock

Shares issued in accordance with the terms of the Amended and Restated Director Deferred Fee Plan.

Each of these units represents a right to receive the cash value of one share of the company's common stock upon the reporting person's separation from the company or an earlier in-service date that the reporting person elected.  The reporting person may reallocate investments in these units to alternative investments in the future.

Includes dividend of 3.745 shares.

Each stock unit represents a conditional right to receive one share of the company's common stock.


Class B Common Stock

Class A Common Stock

Class A Common Stock

Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2025.

The price represents the weighted-average price of the shares sold in multiple transactions ranging from $63.1600 to $64.1400 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price represents the weighted-average price of the shares sold in multiple transactions ranging from $64.1600 to $64.2500 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.  The stock option was granted on September 2, 2020.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

/s/ Jennifer Chaloemtiarana, Attorney-in-Fact


Grant of shares in lieu of cash compensation.


This is the weighted average purchase price for a number of separate purchases executed in the range of $11.93 to $12.12 per share.  Upon request, the reporting person will provide to the SEC Staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

/s/ John F. Brown, as attorney-in-fact for Henning Schroeder


Common Stock

Common Stock

Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.

Not Applicable


Includes: (i) 1,650 shares held by The Weinstein Foundation, a private foundation for which the Reporting Person acts as a trustee and has shared investment and voting power; (ii) 392,538 shares directly owned by the Reporting Person; (iii) 35,000 shares directly owned by the Reporting Person and are held in an IRA; and (iv) 400,000 shares beneficially owned indirectly by the Reporting Person through a limited liability company for the benefit of certain family members of the Reporting Person, in which the Reporting Person has a 10% interest and sole voting power and does not include 6,250 shares issuable to the reporting person pursuant to stock options that are currently exercisable.

The Reporting Person has a 50% interest (113,773 shares) with respect to the securities held in this limited liability company.


Common Stock

Common Stock

The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.

Not Applicable

Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on August 14, 2025. The Reporting Person did not sell shares for any other purpose.

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.19 to $1.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).

The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.


The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a Restricted Stock Units award. Not an open market sale of securities.

/s/ Allison Koehler, Attorney in Fact for Matt Meeker


Ram Shriram TR UA 09/10/2021 2021 RS Irrevocable Trust

Vijay Shriram TR UA 09/10/2021 2021 VS Irrevocable Trust

Ram Shriram TR UA 10/28/2022 2022 RS Irrevocable Trust

Vijay Shriram TR UA 10/28/2022 2022 VS Irrevocable Trust

Ram Shriram TR UA 04/10/2025 2025 RS Irrevocable Trust

Vijay Shriram TR UA 04/10/2025 2025 VS Irrevocable Trust

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $$205 to $206, inclusive. The Reporting Person undertakes to provide to any security holder of Alphabet Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (2) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205 to $206, inclusive.

The Reporting Person is both trustee and sole annuitant of the Ram Shriram Trust UA 09/10/2021.

The Reporting Person's spouse is both trustee and sole annuitant of the Vijay Shriram Trust UA 09/10/2021.

The Reporting Person is trustee and beneficiary of the 2022 RS Irrevocable Trust UAD 10/28/2022.

The Reporting Person's spouse is trustee and beneficiary of the 2022 VS Irrevocable Trust UAD 10/28/2022.

The Reporting Person is both trustee and sole annuitant of the 2025 RS Irrevocable Trust dated 4/10/25.

The Reporting Person's spouse is both trustee and sole annuitant of the 2025 VS Irrevocable Trust dated 4/10/25.

The Google Stock Units (GSUs) entitle the Reporting Person to receive one share of Alphabet Inc. Class C Capital Stock for each share underlying the GSU as GSU vests. 1/48th of GSUs vested on July 25, 2022 and an additional 1/48th of GSUs vests on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates.

1/48th of GSUs vested on July 25, 2023 and an additional 1/48th of GSUs vests on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates.

1/48 of GSUs will vest on the 25th day of each month following the grant date for 31 months and on the 1st day of each month for the following 17 months, subject to continued service on the Board on the applicable vesting dates.

1/48 of GSUs will vest on the 25th day of each month following the grant date for 19 months and on the 1st day of each month for the following 29 months, subject to continued service on the Board on the applicable vesting dates.

All transactions reported in this Form 4 were effected pursuant to Rule 10b5-1 Trading Plans adopted by the Reporting Person and the Reporting Person's spouse on May 30, 2024.

/s/ Valentina Margulis, as Attorney-in-Fact for K. Ram Shriram


Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.


/s/ Laura Anne Kenwick, as attorney-in-fact


Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonqualified Stock Option (Right to Buy)

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Includes 57,646 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date.

Mr. Emmons disclaims ownership of the shares owned by his son.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.

/s/Alessandra Maria Corona Henriques, Attorney-in-Fact


Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,769 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.


Common Stock

This transaction was executed in multiple trades at prices ranging from $7.68 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

On August 14, 2024, the Reporting Person was granted 64,666 restricted stock units that vest in equal installments on each of August 14, 2025, 2026, and 2027. These restricted stock units convert into common stock on a one-to-one basis.

/s/ Bradley J. Wright, as attorney-in-fact


V2X, Inc. Common Stock

These restricted stock units ("RSUs") convert into V2X, Inc. common stock on a one-for-one basis.

Reflects an award of RSUs which are scheduled to vest on the earlier of the date of the V2X, Inc. 2026 Annual Shareholders' Meeting and May 8, 2026.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.75 to $10.76 inclusive. The reporting person undertakes to provide to Farmland Partners Inc., any security holder of Farmland Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

/s/ Christine M. Garrison, as attorney-in-fact for Bruce J. Sherrick


Represents shares withheld to satisfy the Reporting Person's tax obligations in connection with the vesting and settlement of restricted stock units.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025.


Reflects the shares held by The Logan Nicholson Living Trust.

(1) Karen Hager is signing on behalf of Mr. Nicholson pursuant to a power of attorney dated August 6, 2024, which was previously filed with the Securities and Exchange Commission as an exhibit to the Form 3 Mr. Nicholson filed on August 16, 2024.

/s/ Karen Hager on behalf of Logan Nicholson(1)


Common Stock

This option is scheduled to fully vest on the third anniversary of the date of grant and has a 7-year term.

Senior Vice President and Chief Financial Officer

/s/ John L. Healy (POA on file) for Maxwell Krakowiak


Common Stock

The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.

Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.

Not Applicable


This "exit" Form 4 is voluntarily filed solely to report that each Reporting Person is no longer the beneficial owner of more than 10% of the outstanding shares of Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), of Circle Internet Group, Inc. (the "Issuer"), based on 209,836,558 shares of the Class A Common Stock outstanding as of August 8, 2025 as disclosed in the Form 10-Q of the Issuer, filed with the Securities and Exchange Commission on August 12, 2025.


Common Stock

Not applicable.


The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a Restricted Stock Units award. Not an open market sale of securities.


Common Stock

Common Stock

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.

This Form 4 is being filed late due to an inadvertent administrative error.

The RSUs become vested in substantially equal annual installments over the 3 years following August 1, 2025, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.

The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following August 1, 2025, subject to the reporting person's continued service through the applicable vesting date.

/s/ Michael S. Turner, as Attorney-in-Fact


Represents a charitable gift of shares.


by Merrill Lynch under AECOM Retirement & Savings Plan (RSP)

Common Stock

Represents the exercise of a stock option that was exercisable in equal tranches subject to (A) Mr. Rudd's continued employment with the Issuer through the first, second, third, fourth and fifth anniversaries of the 8/15/2020 option grant date, and (B) the volume-weighted average prices of AECOM's common stock on the New York Stock Exchange during any consecutive 20 trading day period exceeding certain price hurdles. The exercise of the stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 11, 2024.

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.94 to $119.56. The Reporting Person undertakes to provide to the Issuer, any
security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted in this footnote.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 11, 2025.

Matt Benson, Attorney-in-Fact for Troy Rudd


Common Stock

Tendered to Issuer to satisfy tax withholding obligations of the Reporting Person incurred in connection with the vesting of the Reporting Person's restricted stock unit awards.

Each restricted stock unit represents a contingent right to receive one share of PTC Inc. common stock.

RSUs granted on July 27, 2023 that vest in three substantially equal installments on August 15, 2024, 2025 and 2026.

This amount represents the total number of derivative securities beneficially owned of the class shown.

/s/Sean McGrath by power of attorney filed 07/19/2023


Common Stock

Common Stock

Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.

Not Applicable


/s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray


/s/ Christine Dryden, Attorney-in-Fact for Scott McDougald Sutton


Common Stock

Represents a total of 5,000 shares of common stock held directly by the Robert Ching Wo Trust 1985 (the "Trust"), of which the reporting person became a co-trustee on September 13, 2019 upon the death of the grantor of the Trust. The reporting person is one of five beneficiaries of the Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest in such securities. These shares were inadvertently omitted from prior filings.

Investment election by reporting person to acquire stock under the Directors' Deferred Compensation Plan at a price equal to the price of derivative security set forth in column 8 (1 for 1).

Investment election by reporting person to acquire Bank of Hawaii stock under the Directors' Deferred Compensation Plan. Distributions to be made at termination of service as a director or earlier at director's option.

/s/Katherine Lamb for WO ROBERT W JR by Power of Attorney


Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.


By Ganesh and Hema Moorthy Revocable Living Trust

/s/ Christine Dryden, Attorney-in-Fact for Ganesh Moorthy


These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.58 to $81.925, inclusive. The Reporting Persons (as defined below) undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.1651 to $82.9893, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.995, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.87, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.09 to $85.995, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.00 to $86.93, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.975, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.01 to $88.975, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.00 to $89.9876, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.1147 to $90.3675, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

This report is filed jointly by Weichai America Corp., Weichai Power Co., Ltd. and Shandong Heavy Industry Group Co., Ltd. (collectively, the "Reporting Persons"). Weichai America Corp. is the direct owner of the Common Stock referenced in this report and shares the power to vote and the power to dispose of all of such shares of Common Stock with the other Reporting Persons. No individual has beneficial ownership over the Common Stock beneficially owned by the Reporting Persons.

Exhibit List:
Exhibit 24.1 - Power of Attorney (Weichai Power Co., Ltd.), incorporated by reference to Exhibit 24.1 to the Form 4 filed by Reporting Persons with the Securities and Exchange Commission on August 14, 2025
Exhibit 24.2 - Power of Attorney (Shandong Heavy Industry Group Co., Ltd.), incorporated by reference to Exhibit 24.2 to the Form 4 filed by Reporting Persons with the Securities and Exchange Commission on August 14, 2025


The reported price in this line is a weighted average sales price.  These shares were sold in multiple transactions at prices ranging from $40.98 to $41.45.  The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price.

/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Disposition of shares to satisfy tax withholding obligations arising from lapse of restrictions applicable to restricted stock units.


Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.


This transaction was executed in multiple trades at prices ranging from $521.56 to $521.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ John K. Stipancich, Attorney-in-fact


Robert D. Vilsack, Attorney-In-Fact for Ronna Romney


Represents shares sold to pay tax withholding obligations in connection with vesting of restricted stock units.

Includes 112 shares purchased on February 14, 2025 and 107 shares purchased on August 14, 2025 pursuant to the Equity Bancshares, Inc. 2019 Employee Stock Purchase Plan.


Common Stock

Common Stock

Includes shares of restricted stock which vest at a rate of 33 1/3% per year commencing on December 2, 2025.

Stock options vest at a rate of 33 1/3% per year commencing on May 25, 2024.

Stock options vest at a rate of 33 1/3% per year commencing on December 2, 2025.

/s/ Victor L. Cangelosi, pursuant to power of attorney


Shares were purchased within the Issuer's Employee Stock Purchase Plan.

/s/ Lynn M. Floeter, by POA from Jayne C. Hladio


Includes 6.3406 shares acquired pursuant to the dividend reinvestment plan.

Includes 16.3488 shares acquired pursuant to the dividend reinvestment plan.

Laura A. Suplee for David M. Lobach Jr. under Power of Attorney dated January 19, 2018


Common Stock

Reflects grant of restricted stock units (RSUs) which vest in three approximately equal installments on each of the three anniversaries of the grant date.

The reporting person elected, in accordance with the Registrant's 2021 Omnibus Stock and Incentive Plan, to exercise his right to have the Registrant withhold 111 shares of the Registrant's common stock to pay income taxes related to vesting of previously granted restricted stock units.

The options vest 33.33% after one year from the grant date, 66.66% after the second year, and 100% after the third year.

Michelle S. Hickox Attorney in Fact for Brian D. Goodrich


Common Stock

The reporting person elected, in accordance with the Registrant's 2021 Omnibus Stock and Incentive Plan, to exercise his right to have the Registrant withhold 127 shares of the Registrant's common stock to pay income taxes related to vesting of previously granted restricted stock units.

By:  Michelle S. Hickox      Attorney in Fact for      J. Kyle McVey


Common Stock

Represents shares held by several trusts of which Mr. Dueser is trustee, settlor and beneficiary.

In connection with the vesting on August 14, 2025, of 4,757 restricted stock units previously granted to the reporting person, the reporting person's receipt of 4,757 shares of common stock was deferred resulting in the reporting person's receipt instead of 4,757 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 4,757  restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

Represents shares that are owned by a family limited partnership of which Mr. Dueser serves as manager of the general partner and to which he disclaims beneficial ownership with respect to 353,253 shares. This report should not be deemed an admission that Mr. Dueser is the beneficial owner of these shares for purposes of Section 16 or any other purpose.

Represents shares that are owned by a family limited partnership of which Mr. Dueser serves as manager of the general partner and to which he disclaims beneficial ownership with respect to 291,125 shares. This report should not be deemed an admission that Mr. Dueser is the beneficial owner of these shares for purposes of Section 16 or any other purpose.

By:  Michelle S. Hickox      Attorney in Fact for      F. Scott Dueser


Common Stock

Common Stock

In connection with the vesting on August 14, 2025, of 453 restricted stock units previously granted to the reporting person, the reporting person's receipt of 453 shares of common stock was deferred resulting in the reporting person's receipt instead of 453 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 453 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      John J. Ruzicka, Jr.


Common Stock

The option vests in three, equal annual installments, which began on February 1, 2023.


Class A common stock, par value $0.01 per share

Farris Wilks, /s/ Matthew Rinaldi, Attorney-in-Fact


UMH Properties, Inc.

UMH Properties, Inc.

UMH Properties, Inc.

These shares are being sold because Mitchell Partners, for which Mitchell Portfolio Management is the fund manager, must liquidate some of its holdings to return capital to its limited partners.


Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $31.96 to $32.085, inclusive.

Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $31.98 to $31.99, inclusive.

/s/ C. Malcolm Holland, III, by power of attorney


Common Stock

Represents the aggregate number of shares of phantom stock allocated to the reporting person under the SERP as of the date hereof based on the closing price of a share of the issuer's Common Stock on August 15, 2025. Each phantom stock unit represents the right to receive one share of common stock.


Common Stock